Home » Stocks » AVDR

Avedro, Inc. (AVDR)

Nov 21, 2019 - AVDR merged into GKOS
Stock Price: $22.99 USD 0.00 (0.00%)
Updated Jan 6, 2020 4:00 PM EST
Market Cap 402.80M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day Jan 6, 2020
Last Price $22.99
Previous Close $22.99
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 22.99 - 22.99
Day's Volume 0
52-Week Range 10.75 - 27.51

News

There are no news available yet.

About AVDR

Avedro, an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness. The company's Avedro Corneal Remodeling platform comprises KXL and Mosaic systems, which deliver ultraviolet A or UVA light, and a suite of single-use riboflavin drug formulations. Its Avedro Corneal Remodeling platform treats corneal ectatic disorders and corrects refractive conditions; and KXL system in combination with Photrexa drug formulations used fo... [Read more...]

Industry
Medical Specialties
IPO Date
Feb 14, 2019
CEO
Reza Zadno
Employees
122
Stock Exchange
NASDAQ
Ticker Symbol
AVDR
Full Company Profile

Financial Performance

In 2018, Avedro's revenue was $27.67 million, an increase of 37.30% compared to the previous year's $20.15 million. Losses were -$25.12 million, 18.1% more than in 2017.

Financial Statements